Australian Clinical Labs Ltd's market cap is currently AU$487.52M. The company's EPS TTM is AU$0.116; its P/E ratio is 14.64; and it has a dividend yield of 5.02%. Australian Clinical Labs Ltd is scheduled to report earnings on August 25, 2025, and the estimated EPS forecast is AU$0.07. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in AUD
Australian Clinical Labs Ltd Earnings and Revenue History
